ClinicalTrials.Veeva

Menu

Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With Meningiomas (MenQOL)

C

Centre Hospitalier St Anne

Status

Enrolling

Conditions

Meningioma
Quality of Life

Treatments

Other: Quality of life

Study type

Observational

Funder types

Other

Identifiers

NCT07044076
D25 - P003

Details and patient eligibility

About

Meningiomas, which account for about 40% of primary central nervous system tumors, have significant psychological and social impacts, even without treatment. Their effect on quality of life is often underestimated and poorly documented. There is one validated questionnaire (MQOL) but it has not yet been translated into French. The project involves two phases: first, translating and linguistically validating the MQOL into French; second, scientifically validating the questionnaire with 50 meningioma patients using established scales (EQ-5D, Karnofsky, FACT-Br) to ensure its reliability and internal consistency.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient aged 18 years or older
  • Diagnosis of intracranial meningioma confirmed by imaging or surgery

Exclusion criteria

  • Pregnant or breastfeeding women (Article L1121-5)
  • Patients deprived of liberty by judicial or administrative decision, as well as individuals undergoing psychiatric care (Article L1121-6)
  • Patients not fluent in French or with poor understanding of the language
  • Inability to refuse participation in the study

Trial contacts and locations

1

Loading...

Central trial contact

Benoît HUDELIST, Dr; Viviane AWASSI

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems